Episcleral brachytherapy (EB) for retinoblastoma (RB)
5 June 2020
| Jonathan Chan
|
EYE - Pathology, EYE - Oncology
|
episcleral brachytherapy, focal consolidation therapy, ocular survival, recurrence-free survival, retinoblastoma
This retrospective study consisted of 11 eyes treated either with Iodine (I) -125 or Ruthenium (R) -106EB with a mean apical dose of 44Gy. There were five in group B (46%), three in group C (27%) and three in group...
Enucleation refusal for retinoblastoma
1 October 2016
| Huw Edward Oliphant
|
Enucleation refusal, global survival disparity, health inequalities, retinoblastoma, treatment compliance, treatment delay
Retinoblastoma is the most common eye cancer in childhood, with enucleation rarely being the only lifesaving surgical option, especially where evidence of extraocular spread is apparent. This study sought to survey a global pool of eye care professionals with regards...
